Becton Dickinson AG Gets FDA 510(k) Clearance and Commercial Launch of BD UltraSafe PLUS™ Passive Needle Guard
4/11/2013 6:52:41 AM
More...
|
Becton Dickinson AG Release: Independent Study Published in Clinical Infectious Diseases Highlights the Importance of Antimicrobial Removal Systems in Blood Culture to Rapidly and Accurately Aid in the Diagnosis of Sepsis
2/28/2013 10:42:53 AM
More...
|
Judge: Becton Dickinson AG Infringed Hologic, Inc. (HOLX)'s Patents
10/4/2012 9:14:46 AM
More...
|
Becton Dickinson AG and Diagenode, Inc. Collaborate to Expand Infectious Disease Menu on the BD MAX(TM) System
5/9/2011 7:52:34 AM
More...
|
Exiqon A/S Licenses Locked Nucleic Acids for Infectious Disease Diagnostics to Becton Dickinson AG
6/21/2010 9:29:47 AM
More...
|
Accelr8 Technology Corporation (OTC-BB: ACLY) And Becton Dickinson AG Conclude Technical Development Project
9/25/2009 11:24:54 AM
More...
|
Option Period Extended on Becton Dickinson AG - Tyrian Diagnostics Agreement
5/13/2009 9:55:45 AM
More...
|
Successful Completion Of NorDiag ASAs Clinical Trial Tailored To The Becton Dickinson AG Probetec(TM) Et System
11/12/2008 3:39:37 PM
More...
|
Becton Dickinson AG Discloses Notice of Arbitration and Dispute Resolution Proceedings
4/25/2007 11:49:59 AM
More...
|
Becton Dickinson AG Says bioMerieux SA Seeks Termination of Pact
4/25/2007 8:45:24 AM
More...
|
|